COMMUNIQUÉS West-GlobeNewswire

HEXO Corp’s Agnes Kwasniewska named Master Grower of the Year
16/09/2019
Canada’s first female Master Grower recognized at the inaugural Grow Up Awards GATINEAU, Quebec, Sept. 16, 2019 (GLOBE NEWSWIRE) -- HEXO Corp (“HEXO” or the “Company”) (TSX: HEXO; NYSE: HEXO) is thrilled to announce [...]
Agnes Kwasniewska de HEXO Corp remporte le prix de Maître Cultivateur de l'année
16/09/2019
Première femme maître cultivatrice du Canada récompensée lors de la cérémonie inaugurale des prix Grow Up GATINEAU, Québec, 16 sept. 2019 (GLOBE NEWSWIRE) -- HEXO Corp (« HEXO » ou la « Société ») (TSX : HEXO ; NYSE : [...]
Establishment Labs Receives Notice of Allowance for Key U.S. Patent Application Covering Company’s Implant Surface Technology and Announces 510(k) Submission for its Tissue Expander
16/09/2019
NEW YORK, Sept. 16, 2019 (GLOBE NEWSWIRE) -- Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, today [...]
National Osteoporosis Foundation Supports New Evidence-Based Care Pathway Designed to Optimize Care for Vertebral Compression Fractures (VCF)
16/09/2019
Pathway Helps Physicians Better Identify Which Patients to Treat with Vertebral Augmentation, Which to Manage with Conservative Care DUBLIN, Sept. 16, 2019 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT), the global leader [...]
Innovation Pharmaceuticals Announces Successful Formulation of Oral Brilacidin Tablets; Upcoming Clinical Trial to Target Delivery to the Colon
16/09/2019
BEVERLY, Mass., Sept. 16, 2019 (GLOBE NEWSWIRE) -- Innovation Pharmaceuticals (OTCQB:IPIX) (“the Company”), a clinical stage biopharmaceutical company, is pleased to inform shareholders that BDD Pharma, the Company’s [...]
In August revenues increased by 14%, strong growth in Latvia and Russia
16/09/2019
JSC Olainfarm preliminary consolidated results for August 2019 indicate that revenues increased by 14% compared to the same month last year and reach 10.5 million euro. At the same time consolidated results for the [...]
Parexel Expands Phase I Research Capabilities in Greater China region with New Early Phase Clinical Unit Alliances
16/09/2019
Local specialist Chinese medical centers combined with Parexel’s industry-leading Early Phase expertise help to support life sciences companies in navigating the China market from earliest stages of development BOSTON [...]
OrthoPediatrics Corp. to Sponsor Three Medical Meetings in September 2019
16/09/2019
WARSAW, Ind., Sept. 16, 2019 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQ: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, announced today it will continue [...]
Peer-Reviewed Journal Future Oncology Publishes Two Manuscripts on Cancer Metabolism and Drug Candidate CPI-613® (Devimistat)
16/09/2019
Cranbury, NJ, Sept. 16, 2019 (GLOBE NEWSWIRE) -- Rafael Pharmaceuticals Inc. (“Rafael” or the “Company”), a leader in the growing field of cancer metabolism-based therapeutics, announced today that peer-reviewed medical [...]
Polydex Pharmaceuticals Issues Second Quarter Financial Results
16/09/2019
Positive Cash Flow Key to Forward Momentum TORONTO, Sept. 16, 2019 (GLOBE NEWSWIRE) -- Polydex Pharmaceuticals Limited (Pink Sheets:POLXF) (the “Company”) is pleased to report financial results for the second quarter of [...]
Cerner Announces New Chief Marketing Officer
16/09/2019
Darrell Johnson Named Senior Vice President & CMO KANSAS CITY, Mo., Sept. 16, 2019 (GLOBE NEWSWIRE) -- Cerner Corporation (Nasdaq: CERN) announced today that Darrell Johnson is joining the company in the newly [...]
Novo Nordisk A/S – Share repurchase programme
16/09/2019
Bagsværd, Denmark, 16 September 2019 – On 9 August 2019, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council of 16 April 2014 [...]
Emerald Health Therapeutics participera à la conférence mondiale sur le cannabis organisée par Eight Capital & Cassels Brock
16/09/2019
VANCOUVER, Colombie-Britannique, 16 sept. 2019 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (« Émeraude ») (TSXV : EMH; OTCQX : EMHTF) a annoncé aujourd'hui sa participation à un panel et sa disponibilité pour [...]
Marrone Bio Announces Closing of Pro Farm Technologies Acquisition
16/09/2019
New Subsidiary Enters into Strategic, Long-Term Exclusive Commercial Agreement in Europe with Corteva Agriscience DAVIS, Calif., Sept. 16, 2019 (GLOBE NEWSWIRE) -- Marrone Bio Innovations Inc. (NASDAQ: MBII), an [...]
Cassava Sciences Initiates Phase 2b Clinical Study in Alzheimer’s Patients
16/09/2019
First two patients dosed with lead drug candidate, PTI-125 Study initiation follows positive Phase 2a results demonstrating 100% response rate AUSTIN, Texas, Sept. 16, 2019 (GLOBE NEWSWIRE) -- Cassava Sciences, Inc. ( [...]
Bellerophon Receives Orphan Drug Designation for Nitric Oxide in the Treatment of Idiopathic Pulmonary Fibrosis
16/09/2019
WARREN, N.J., Sept. 16, 2019 (GLOBE NEWSWIRE) -- Bellerophon Therapeutics, Inc. (Nasdaq: BLPH) (“Bellerophon” or the “Company”), a clinical-stage biotherapeutics company, announced today the U.S. Food and Drug [...]
Resverlogix Provides Update on BETonMACE Phase 3 Trial
16/09/2019
Top-line results projected to be available on or about September 30, 2019 Number of MACE increases from 250 to greater than 275 CALGARY, Alberta, Sept. 16, 2019 (GLOBE NEWSWIRE) -- Resverlogix Corp. (“Resverlogix” or [...]
Nova Leap Health Corp. Announces Update on South Central U.S. Acquisition
16/09/2019
NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES AND DOES NOT CONSTITUTE AN OFFER OF THE SECURITIES DESCRIBED HEREIN HALIFAX, Nova Scotia, Sept. 16, 2019 (GLOBE NEWSWIRE) -- NOVA [...]
Auransa to Present New Data on AU-409, a Novel, AI-Generated Drug Candidate for the Treatment of Hepatocellular Carcinoma, at the 13th Annual Conference of the International Liver Cancer Association
16/09/2019
Oral Presentation to Highlight Promising Preclinical Activity of Unique Orally Active Small Molecule PALO ALTO, Calif., Sept. 16, 2019 (GLOBE NEWSWIRE) -- Auransa Inc., an artificial intelligence (AI)-driven [...]

Pages